Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 28;5(1):2324709617690742.
doi: 10.1177/2324709617690742. eCollection 2017 Jan-Mar.

Nodular Regenerative Hyperplasia: A Case of Rare Prognosis

Affiliations

Nodular Regenerative Hyperplasia: A Case of Rare Prognosis

Mindy Lee et al. J Investig Med High Impact Case Rep. .

Abstract

Introduction: Nodular regenerative hyperplasia (NRH) is a known etiology of noncirrhotic portal hypertension. Cases of biopsy-proven NRH in human immunodeficiency virus (HIV)-positive patients have been described. While these patients often have normal synthetic liver function, several reports described disease progression to liver failure. Case: We here present a 26-year-old woman with history of congenital HIV on antiretroviral therapy complicated by Pneumocystis carinii pneumonia at age 14. CD4 counts have been >300 with undetectable viral load. She was referred to our Hepatology service for evaluation of splenomegaly, elevated liver tests, and thrombocytopenia. On initial presentation, she reported easy bruising and gingival bleeding, and abdominal imaging showed evidence of portal hypertension without associated cirrhosis. Upper endoscopy was significant for large esophageal varices without bleeding stigmata. Liver biopsy showed minimal fibrosis around the portal areas without significant inflammation. The lobules showed focal zones of thin hepatocyte plates on reticulin stain with adjacent areas showing mild regenerative changes. The diagnosis of NRH was made and patient was placed on propranolol for variceal bleeding prophylaxis. Two years later, the patient presented with bleeding gastric varices warranting transjugular intrahepatic portosystemic shunt. Postprocedure course was complicated by mild encephalopathy. Subsequent magnetic resonance imaging showed a 1.7 × 1.3 cm lesion suggestive of hepatocellular carcinoma (HCC). The patient was deemed to be a candidate for liver transplantation, and she is now delisted due to ongoing pregnancy. Conclusion: This report describes the first case of HCC in an HIV patient with NRH. The possible association of NRH with HCC warrants further investigation.

Keywords: Hepatocellular carcinoma; Hepatoma; Nodular regenerative hyperplasia; Noncirrhotic portal hypertension.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Hematoxylin and eosin stain of liver biopsy. The hepatocytes between the nodules are compressed and atrophic (blue arrow). The liver biopsy slide does not belong to the case reported in this article as its slides were accidentally damaged under unexpected circumstances. The slide is provided to clearly illustrate the histologic features of nodular regenerative hyperplasia.
Figure 2.
Figure 2.
Reticulin stain of liver biopsy. The reticulin network is compressed in the parenchyma between the nodules (red arrows). Hepatocytes within nodules are arranged in plates that are 1 to 2 cells thick (blue arrow). The liver biopsy slide does not belong to the case reported in this article as its slides were accidentally damaged under unexpected circumstances. The slide is provided to clearly illustrate the histologic features of nodular regenerative hyperplasia.
Figure 3.
Figure 3.
Hepatocellular carcinoma (arrows) with arterial enhancement (arterial phase).
Figure 4.
Figure 4.
Washout during the venous phase.
Figure 5.
Figure 5.
Hepatocellular carcinoma (arrows) on hepatobiliary phase.

Similar articles

Cited by

References

    1. Sood A, Castrejón M, Saab S. Human immunodeficiency virus and nodular regenerative hyperplasia of liver: a systematic review. World J Hepatol. 2014;6:55-63. - PMC - PubMed
    1. Hartleb M, Gutkowski K, Milkiewicz P. Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol. 2011;17:1400-1409. - PMC - PubMed
    1. Cotte L, Bénet T, Billioud C, et al. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study. J Hepatol. 2011;54:489-496. - PubMed
    1. Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol. 2004;75:225-230. - PubMed
    1. Maida I, Núñez M, Ríos MJ, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr. 2006;42:177-182. - PubMed

LinkOut - more resources